After finishing at $21.39 in the prior trading day, Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) closed at $20.33, down -4.96%. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 971384 shares were traded.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Our goal is to gain a better understanding of SNDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.60 and its Current Ratio is at 18.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 09 when Morrison Briggs sold 52,855 shares for $21.41 per share. The transaction valued at 1,131,478 led to the insider holds 17,836 shares of the business.
Morrison Briggs sold 52,855 shares of SNDX for $1,032,237 on Apr 10. The Director now owns 17,836 shares after completing the transaction at $19.53 per share. On Mar 13, another insider, Morrison Briggs, who serves as the President, Head of R&D of the company, sold 52,854 shares for $22.53 each. As a result, the insider received 1,190,674 and left with 17,836 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1.40B and an Enterprise Value of 912.02M. Its current Enterprise Value per Revenue stands at 7.85 whereas that against EBITDA is -6.05.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $29.86, while it has fallen to a 52-week low of $13.88. The 50-Day Moving Average of the stock is 20.98, while the 200-Day Moving Average is calculated to be 23.41.
The stock has traded on average 893.08K shares per day over the past 3-months and 964.14k shares per day over the last 10 days, according to various share statistics. A total of 69.44M shares are outstanding, with a floating share count of 57.43M. Insiders hold about 0.30% of the company’s shares, while institutions hold 90.20% stake in the company. Shares short for SNDX as of Apr 27, 2023 were 6.52M with a Short Ratio of 6.39M, compared to 7.63M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 9.53% and a Short% of Float of 12.47%.
Its stock is currently analyzed by 7 different market analysts. On average, analysts expect EPS of -$0.73 for the current quarter, with a high estimate of -$0.7 and a low estimate of -$0.81, while EPS last year was -$0.62. The consensus estimate for the next quarter is -$0.83, with high estimates of -$0.7 and low estimates of -$0.91.
Analysts are recommending an EPS of between -$2.32 and -$3.35 for the fiscal current year, implying an average EPS of -$3.06. EPS for the following year is -$3.01, with 9 analysts recommending between -$2.23 and -$3.96.
Based on 9 analysts’ estimates, the company’s revenue will be $53.33M in the next fiscal year. The high estimate is $123.62M and the low estimate is $11.59M. The average revenue growth estimate for next year is up 442.50% from the average revenue estimate for this year.